• Consistency matters: try not to vary the time significantly day-to-day.
• If you get stomach upset: some people find it easier to take when they can manage minor gastrointestinal symptoms.
• Missed dose: if you miss a dose, take it when you remember unless it is close to the next dose. Do not double up.

7) Food interactions and eating with Daliresp

Food may affect how some medicines are absorbed. For roflumilast, it is generally recommended to take it according to the instructions given for your specific product.

• Typical approach: many roflumilast regimens can be taken with or without food, but tolerability may be improved with a meal.
• Practical tip: if you experience nausea or diarrhoea, taking the tablet with food may help.
• Avoid sudden diet changes: because weight loss can occur as a side effect, maintaining adequate nutrition is important.

8) Alcohol and medicine interactions

Alcohol

There is not one single rule for everyone, but alcohol can worsen stomach irritation and dehydration risk. Since roflumilast may cause diarrhoea and other gastrointestinal effects, it may be wise to limit alcohol, especially when starting treatment or if side effects are present.

• Be cautious: if you experience diarrhoea, nausea, dizziness, or reduced appetite.
• Stay hydrated: especially during hot weather or if you have loose stools.

Medicine interactions

Roflumilast is metabolised mainly by liver enzymes. Some medicines can change its levels, affecting effectiveness and side-effect risk. Always keep a healthcare professional aware of all medicines and supplements you take.

Key interaction examples (general categories):

• CYP enzyme inducers (can reduce roflumilast levels): e.g., certain anti-epilepsy medicines such as carbamazepine, phenytoin, phenobarbital; and some treatments for infections such as rifampicin.
• Strong CYP inhibitors (can increase roflumilast levels): may raise risk of adverse effects (e.g., gastrointestinal symptoms).
• Other medicines for COPD: inhaled therapies and rescue inhalers may be used alongside Daliresp as part of an overall plan, but medication reviews are important.

If you take multiple medicines, consider keeping an up-to-date list for clinic visits and pharmacy dispensing checks.

9) Indications – who should consider Daliresp?

Daliresp is indicated for maintenance treatment in adults with severe COPD associated with:

• Chronic bronchitis (often described as long-term cough with phlegm), and
• A history of exacerbations

In practice, suitability depends on your COPD pattern, symptom history, other treatments (especially inhalers), and your health profile (including weight and mood history).

10) Safety profile and side effects

Most people tolerate Daliresp with monitoring and appropriate supportive care. However, it can cause side effects, and some require prompt medical advice.

Common side effects

• Diarrhoea
• Nausea
• Weight loss (important to monitor)
• Headache
• Abdominal pain or discomfort
• Decreased appetite
• Dizziness (less common)

Serious side effects – get medical help urgently if

• Severe or persistent diarrhoea, signs of dehydration (e.g., marked thirst, reduced urination, weakness).
• Unplanned significant weight loss, especially if you become underweight.
• Mood changes, including new or worsening depression, or thoughts of self-harm. If mood symptoms occur, it’s important to seek advice quickly.
• Allergic reaction (e.g., swelling of face/lips, rash with breathing difficulties).

Who needs extra caution?

• Low body weight or a history of weight loss.
• History of depression or mood disorders.
• Significant gastrointestinal problems (e.g., recurrent diarrhoea).
• Liver disease (your clinician may assess suitability and monitor you more closely).

11) Practical use tips (to help you stay on track)

The following tips can make treatment easier and help reduce the chance of problems:

• Track weight: weigh yourself regularly (for example, weekly) and report unexpected weight loss.
• Manage diarrhoea early: if diarrhoea starts, focus on hydration. Your healthcare professional can advise on appropriate measures. If symptoms are severe or persistent, seek advice promptly.
• Don’t ignore mood changes: if you notice depression symptoms, anxiety, irritability, or unusual thoughts, contact a healthcare professional promptly.
• Keep inhaler technique in check: Daliresp is an add-on for exacerbation prevention; inhaled maintenance therapy and correct technique remain essential for COPD control.
• Use one daily reminder: phone alarms or pill organisers can help you take it on schedule.
• Review all medicines: bring your list of prescriptions, over-the-counter medicines, and supplements to your pharmacy review.

12) What to do if you miss a dose

If you forget a dose, take it when you remember unless it is close to your next dose. Do not take a double dose to make up for a missed tablet.

If you frequently miss doses, it may help to discuss adherence strategies with a pharmacist.

13) Special considerations

Pregnancy and breastfeeding

If you are pregnant, planning pregnancy, or breastfeeding, discuss this with your healthcare professional. There may be uncertainty about risks, and your care plan may need adjustment.

Driving and operating machinery

Dizziness or other effects may occur in some people. If you feel unwell, avoid driving or operating machinery until you know how the medicine affects you.

14) Alternative options for COPD exacerbation prevention

COPD management is individual and depends on your symptoms, exacerbation history, lung function, and blood markers. Depending on your case, alternatives may include different classes of maintenance medicines or biologics.

Common alternative approaches may include

• Optimised inhaled therapy (e.g., long-acting bronchodilators, and combinations as appropriate).
• Inhaled corticosteroids for selected patients, especially those with frequent exacerbations and relevant risk features (as advised by guidelines).
• Macrolide antibiotics in certain circumstances (specialist-led decisions).
• Biologic/targeted therapies for specific COPD phenotypes in specialist pathways (e.g., based on eosinophils and other factors).
• Non-drug measures such as pulmonary rehabilitation, smoking cessation support, vaccination, and exercise plans.

Your clinician can help you weigh benefits and risks of each option based on your personal COPD profile.

15) Pharmacokinetics (what the body does to roflumilast)

Pharmacokinetics describes how roflumilast is absorbed, distributed, metabolised, and eliminated. While individual results vary, the following provides a helpful overview.

• Absorption: roflumilast is absorbed after oral dosing. The active metabolite contributes to overall effect.
• Metabolism: roflumilast is metabolised mainly in the liver. A major active metabolite is roflumilast N-oxide.
• Distribution: it distributes into body tissues; protein binding is relevant for how much is available to act.
• Elimination: it is eliminated primarily through metabolism and excretion. Clearance may vary with liver function and other factors.
• Half-life (general principle): the active metabolite persists longer, supporting once-daily dosing.

Your prescriber may adjust monitoring based on liver function, co-medications, and tolerability.

16) UK market and legal context (what to expect in the UK)

In the UK, medicines such as Daliresp are regulated and supplied under national medicines frameworks. In practice, access is organised through routine NHS and private healthcare pathways and depends on clinical need and suitability.

Daliresp is an established product within its therapeutic class. As with all medicines, ongoing safety monitoring continues through UK pharmacovigilance processes. Patients are encouraged to report suspected side effects to relevant bodies when appropriate.

Recent guidance (general theme)

UK COPD treatment guidance continues to emphasise:

• the use of inhaled maintenance therapy tailored to symptoms and exacerbation risk,
• the importance of exacerbation prevention strategies beyond inhalers,
• careful patient selection for add-on medicines,
• monitoring for side effects such as weight changes and mood symptoms.

Where Daliresp is considered, clinicians usually review exacerbation history, symptom burden, nutritional status, and comorbidities.

17) Delivery and availability (UK online pharmacy)

Availability can vary by strength, pack size, and current supply levels. If you are ordering online from the UK, you can typically expect:

• Standard and express delivery options (depending on the pharmacy’s service level).
• Packaging designed for safe transport.
• Order tracking where offered.
• Planned dispatch times that can differ on weekends and public holidays.

If stock is temporarily unavailable, some pharmacies may offer updates or alternative arrangements. Check your retailer’s page for exact delivery timelines and stock status.

18) Storage instructions

• Keep tablets in their original packaging.
• Store at room temperature, away from excessive heat and moisture.
• Keep out of sight and reach of children.
• Do not use after the expiry date on the pack.

19) FAQ

Can I use Daliresp for sudden breathlessness?

No. Daliresp is not intended as a quick-relief medicine. It is used as longer-term maintenance treatment to help reduce COPD exacerbations. For sudden symptoms, follow your usual emergency plan and rescue inhaler instructions.

How long does it take Daliresp to work?

COPD exacerbation prevention is assessed over time. Some people notice changes in their overall pattern of flare-ups after several weeks, but the full benefit may take longer. Consistency is important.

What should I do if I get diarrhoea?

Start by focusing on hydration and tell your healthcare professional if diarrhoea is persistent, severe, or worsening. If you develop signs of dehydration or cannot keep fluids down, seek urgent medical advice.

Will Daliresp cause weight loss?

Weight loss can occur in some people. This is one of the key side effects to monitor. Regular weighing and early reporting of significant changes to a healthcare professional can help manage risk.

Is Daliresp safe if I have depression or mood problems?

Extra caution is needed. If you have a history of depression or mood disorders, discuss this before starting treatment, and monitor for new or worsening mood symptoms. Seek advice promptly if mood changes occur.

Can I take it with food?

Many people can take roflumilast with or without food. If you experience nausea or stomach upset, taking it with food may help. Follow the instructions for your specific product and your healthcare professional’s advice.

Are there common drug interactions?

Yes. Medicines that influence liver enzymes can change roflumilast levels. Always provide your pharmacist with a full list of medicines, including over-the-counter products and supplements.

Can I drink alcohol while taking Daliresp?

Alcohol can worsen gastrointestinal side effects in some people. If you experience diarrhoea, nausea, or reduced appetite, consider limiting alcohol and discuss your situation with a pharmacist or clinician.

What happens if I stop taking Daliresp?

Stopping may reduce the medicine’s preventive effect against exacerbations. If you are considering stopping due to side effects or other reasons, discuss alternatives and an action plan with a healthcare professional.

Where can I find help if I experience side effects?

Contact your healthcare professional or pharmacist. If you have severe symptoms (such as severe diarrhoea, signs of dehydration, allergic reaction, or significant mood changes), seek urgent help.

Summary

Daliresp (roflumilast) is a PDE4 inhibitor used in selected adults with severe COPD—particularly those with chronic bronchitis and a history of exacerbations—to help reduce flare-ups over time. It is taken once daily and should be used as part of an overall COPD management plan. Common side effects include gastrointestinal symptoms and weight loss, and it is important to monitor both nutrition and mood. If you have questions about suitability, dosing timing, or interactions, a pharmacist can help.